Cohort study

Permanent Pacemaker Implantation and Long-Term Outcomes of Patients Undergoing Concomitant Mitral and Tricuspid Valve Surgery

J Am Coll CardiolPublished

  • Retrospective cohort study
  • propensity-score weighted
  • 90-day conditional landmark analysis
  • New York and California state discharge databases

Authors' conclusion

Compared to isolated MVr, adding TA to MVr was associated with a higher risk of 90-day PPM implantation. In both surgical groups, PPM implantation was associated with an increase in mortality, HFH, and endocarditis.

Study context

Population
Patients undergoing isolated mitral valve repair (MVr) or MVr with concomitant tricuspid annuloplasty (TA), New York and California, 2004–2019isolated MVr 28,003
Participants
32,736 patients
Exposure
Permanent pacemaker (PPM) vs no PPM within 90 days after MVr or MVr + TA
Outcome
Incidence of PPM implantation after isolated MVr and MVr + TA, and long-term consequences of PPM (survival, HF hospitalization, endocarditis, stroke, reoperation)
Follow-up
<90 days after surgery (PPM)

Main finding

As reported in the abstract

PPM implantation <90 days and long-term survival
PPM vs No PPMHazard ratio (95% CI)P value
reduced long-term survival, MVr
1.96(1.75–2.19)
P < 0.001
reduced long-term survival, MVr + TA
1.65(1.28–2.14)
P < 0.001

Observational data: associations, not effects.

Further findings

OutcomeHR (95% CI)P value
HF hospitalization (both surgical groups)1.56 (1.27–1.90)P < 0.001
Endocarditis (both surgical groups)1.95 (1.52–2.51)P < 0.001

Stroke, reoperation

PPM not associated with stroke or reoperation

Temporal trends

Annual MVr + TA volumes increased
P < 0.001, trend
PPM rates decreased
P < 0.001, trend

Original publication

Permanent Pacemaker Implantation and Long-Term Outcomes of Patients Undergoing Concomitant Mitral and Tricuspid Valve Surgery. J Am Coll Cardiol. Published 30 April 2024. doi:10.1016/j.jacc.2024.02.042

Summarised from the published abstract; every number is checked against it